PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28246473-11 2017 By contrast, poly I:C pretreatment markedly reversed the DSS-induced up-regulated expressions of the inflammatory cytokines TNF-alpha, IL-17 and IFN-gamma. Poly I-C 13-21 interleukin 17A Mus musculus 135-140 24055691-7 2013 Furthermore, polyIC-treated RPE caused a robust stimulation of differentiation of CD4 cell toward Th1 or Th17 cells, in addition to the secretion of the cytokines IFNgamma and IL-17. Poly I-C 13-19 interleukin 17A Mus musculus 176-181 23618691-5 2013 In addition, Poly I:C supplementation could reduce inflammation through the up-regulation of memory T cells and IL-15Ralpha+ cells accompany with down-regulation of pro-inflammatory cytokine, IL-17A in BD mice. Poly I-C 13-21 interleukin 17A Mus musculus 192-198 19443727-9 2009 IRBP-specific T cells activated by polyI:C-treated RACs expanded vigorously, produced significant amounts of IFN-gamma and IL-17, and induced experimental autoimmune uveitis when injected into naive mice. Poly I-C 35-42 interleukin 17A Mus musculus 123-128 22882449-3 2012 The aim of the study was to evaluate the activity of polyinosinic-polycytidylic acid [poly(I:C)] on IL-17A production by CD1d-activated iNKT cells. Poly I-C 53-84 interleukin 17A Mus musculus 100-106 22882449-3 2012 The aim of the study was to evaluate the activity of polyinosinic-polycytidylic acid [poly(I:C)] on IL-17A production by CD1d-activated iNKT cells. Poly I-C 86-95 interleukin 17A Mus musculus 100-106 34983106-7 2022 In ovalbumin-induced asthma mice, Poly I-C treatment significantly increased SAA1 levels as well as IL-17A/interferon-gamma/IL-33 levels in bronchoalveolar lavage fluid (BALF), leading to airway hyperresponsiveness and inflammation. Poly I-C 34-42 interleukin 17A Mus musculus 100-106 28913994-0 2017 Mouse Model of IL-17-Dominant Rhinitis Using Polyinosinic-Polycytidylic Acid. Poly I-C 45-76 interleukin 17A Mus musculus 15-20 32641167-0 2020 The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma. Poly I-C 36-42 interleukin 17A Mus musculus 4-9 32009087-2 2020 Recent animal model on MIA induced by polyinosinic:polycytidylic acid, a mimic of viral infection, demonstrates that maternal interleukin 17A (IL-17A) signaling is required for the development of autism spectrum disorder (ASD)-like behaviors of offspring. Poly I-C 38-69 interleukin 17A Mus musculus 126-141 32009087-2 2020 Recent animal model on MIA induced by polyinosinic:polycytidylic acid, a mimic of viral infection, demonstrates that maternal interleukin 17A (IL-17A) signaling is required for the development of autism spectrum disorder (ASD)-like behaviors of offspring. Poly I-C 38-69 interleukin 17A Mus musculus 143-149 28913994-3 2017 Our objective was to establish a mouse model of IL-17-dominant rhinitis via intranasal application of polyinosinic-polycytidylic acid (abbreviated as Poly(I:C)). Poly I-C 102-133 interleukin 17A Mus musculus 48-53